These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Treatment of bisphosphonate-resistant hypercalcemia of malignancy with calcitonin. Dawson C; Todd AM; Walton A J Palliat Med; 2014 Oct; 17(10):1084. PubMed ID: 25265187 [No Abstract] [Full Text] [Related]
65. Bortezomib: killing two birds with one stone in gastrointestinal stromal tumors. Duensing S; Duensing A Oncotarget; 2010 May; 1(1):6-8. PubMed ID: 21293050 [No Abstract] [Full Text] [Related]
66. Mismanagement of malignant hypercalcaemia. Lightowlers S; Patterson D Clin Med (Lond); 2013 Feb; 13(1):118. PubMed ID: 23472518 [No Abstract] [Full Text] [Related]
67. Malignant acanthosis nigricans in a patient with a gastrointestinal stromal tumor. Park KW; Lim DH; Lee SI Korean J Intern Med; 2013 Sep; 28(5):632-3. PubMed ID: 24009466 [No Abstract] [Full Text] [Related]
68. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient. Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480 [TBL] [Abstract][Full Text] [Related]
69. Non-islet cell tumour hypoglycaemia in a patient with a gastrointestinal stromal tumour. Rikhof B; Van Den Berg G; Van Der Graaf WT Acta Oncol; 2005; 44(7):764-6. PubMed ID: 16227170 [No Abstract] [Full Text] [Related]
71. Re: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment. Tsuda M; Ishiguro H; Yano I; Toi M J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906398 [No Abstract] [Full Text] [Related]
72. RE: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment. Adhikaree J; Newby Y; Sundar S J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663690 [No Abstract] [Full Text] [Related]
74. Hypercalcaemia in an immobilised patient with pneumonia. Mark S Br J Clin Pract; 1995; 49(6):327-9. PubMed ID: 8554961 [TBL] [Abstract][Full Text] [Related]
75. [Therapeutic possibilities in paraneoplastic hypercalcemia]. Schürer CC; Peters U; Fischer JT Med Welt; 1981 Aug; 32(32-33):1219-21. PubMed ID: 6456397 [No Abstract] [Full Text] [Related]
76. Hypercalcemia of immobilization. Labossiere R; Hintzke C; Ileana S J Am Med Dir Assoc; 2009 May; 10(4):284-5. PubMed ID: 19426949 [No Abstract] [Full Text] [Related]
77. [Answers to questions on hypercalcemia from PRAXIS No. 5]. Praxis (Bern 1994); 2009 Mar; 98(6):347. PubMed ID: 19291645 [No Abstract] [Full Text] [Related]
78. Hypercalcaemia in gastrointestinal stromal tumour and sarcoidosis: a case report. Selvananthan B; Fischer E; Lin R BMC Nephrol; 2024 Jul; 25(1):229. PubMed ID: 39030472 [TBL] [Abstract][Full Text] [Related]
79. [Hypercalcaemia and malignant lymphoma. One case report]. Frein D; Lavigne C; Josselin N; Foussard C; Sivova N; Moles MP; Berrut G Rev Med Interne; 2007 Oct; 28(10):714-5. PubMed ID: 17544176 [TBL] [Abstract][Full Text] [Related]
80. Effects of diphosphonates in hypercalcaemia due to neoplasia. Kanis JA; Percival RC; Yates AJ; Urwin GH; Hamdy NA Lancet; 1986 Mar; 1(8481):615-6. PubMed ID: 2869324 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]